APO Research
Talk to an analyst

APO RESEARCH · REPORT

EPA and DHA

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global EPA and DHA Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchEPA and DHA Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal EPA and DHA Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal EPA and DHA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EPA and DHA Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal EPA and DHA Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global EPA and DHA market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EPA and DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EPA and DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EPA and DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EPA and DHA market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EPA and DHA market include DSM, Tianhecheng, Lonza, Yidie, Stepan, Runke, Novotech Nutraceuticals, Kingdomway and Fuxing, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EPA and DHA market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EPA and DHA and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EPA and DHA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA and DHA market size, projected growth trends, production technologies, key applications, and end-use industries.

EPA and DHA Segment by Company

DSM

Tianhecheng

Lonza

Yidie

Stepan

Runke

Novotech Nutraceuticals

Kingdomway

Fuxing

Cabio

Arjuna Natural

EPA and DHA Segment by Type

EPA

DHA

EPA and DHA Segment by Application

Infant Formula

Food and Beverage

Dietary Supplements

Others

EPA and DHA Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global EPA and DHA status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions EPA and DHA market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EPA and DHA significant trends, drivers, influence factors in global and regions.

6. To analyze EPA and DHA competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA and DHA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA and DHA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA and DHA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EPA and DHA market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EPA and DHA industry.

Chapter 3: Detailed analysis of EPA and DHA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of EPA and DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of EPA and DHA in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EPA and DHA Industry Trends Table 2. EPA and DHA Industry Drivers Table 3. EPA and DHA Industry Opportunities and Challenges Table 4. EPA and DHA Industry Restraints Table 5. Global EPA and DHA Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EPA and DHA Revenue Share by Company (2021-2026) Table 7. Global EPA and DHA Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global EPA and DHA Sales Volume Share by Company (2021-2026) Table 9. Global EPA and DHA Average Price (US$/Ton) of Company (2021-2026) Table 10. Global EPA and DHA Company Ranking, (2024-2026) & (USD Million) Table 11. Global EPA and DHA Key Company Manufacturing Base & Headquarters Table 12. Global EPA and DHA Company, Product Type & Application Table 13. Global EPA and DHA Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global EPA and DHA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of EPA Table 18. Significant Companies of DHA Table 19. Global EPA and DHA Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global EPA and DHA Sales Volume by Type (2021-2026) & (K Tons) Table 21. Global EPA and DHA Sales Volume by Type (2027-2032) & (K Tons) Table 22. Global EPA and DHA Sales Volume Share by Type (2021-2026) Table 23. Global EPA and DHA Sales Volume Share by Type (2027-2032) Table 24. Global EPA and DHA Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global EPA and DHA Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global EPA and DHA Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global EPA and DHA Sales Value Share by Type (2021-2026) Table 28. Global EPA and DHA Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Infant Formula Table 30. Significant Companies of Food and Beverage Table 31. Significant Companies of Dietary Supplements Table 32. Significant Companies of Others Table 33. Global EPA and DHA Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 34. Global EPA and DHA Sales Volume by Application (2021-2026) & (K Tons) Table 35. Global EPA and DHA Sales Volume by Application (2027-2032) & (K Tons) Table 36. Global EPA and DHA Sales Volume Share by Application (2021-2026) Table 37. Global EPA and DHA Sales Volume Share by Application (2027-2032) Table 38. Global EPA and DHA Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global EPA and DHA Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global EPA and DHA Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global EPA and DHA Sales Value Share by Application (2021-2026) Table 42. Global EPA and DHA Sales Value Share by Application (2027-2032) Table 43. Global EPA and DHA Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 44. Global EPA and DHA Sales by Region (2021-2026) & (K Tons) Table 45. Global EPA and DHA Sales Market Share by Region (2021-2026) Table 46. Global EPA and DHA Sales by Region (2027-2032) & (K Tons) Table 47. Global EPA and DHA Sales Market Share by Region (2027-2032) Table 48. Global EPA and DHA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global EPA and DHA Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global EPA and DHA Sales Value Share by Region (2021-2026) Table 51. Global EPA and DHA Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global EPA and DHA Sales Value Share by Region (2027-2032) Table 53. Global EPA and DHA Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global EPA and DHA Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global EPA and DHA Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. Global EPA and DHA Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global EPA and DHA Sales by Country (2021-2026) & (K Tons) Table 58. Global EPA and DHA Sales Market Share by Country (2021-2026) Table 59. Global EPA and DHA Sales by Country (2027-2032) & (K Tons) Table 60. Global EPA and DHA Sales Market Share by Country (2027-2032) Table 61. Global EPA and DHA Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global EPA and DHA Sales Value Market Share by Country (2021-2026) Table 63. Global EPA and DHA Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global EPA and DHA Sales Value Market Share by Country (2027-2032) Table 65. DSM Company Information Table 66. DSM Business Overview Table 67. DSM EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. DSM EPA and DHA Product Portfolio Table 69. DSM Recent Development Table 70. Tianhecheng Company Information Table 71. Tianhecheng Business Overview Table 72. Tianhecheng EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Tianhecheng EPA and DHA Product Portfolio Table 74. Tianhecheng Recent Development Table 75. Lonza Company Information Table 76. Lonza Business Overview Table 77. Lonza EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Lonza EPA and DHA Product Portfolio Table 79. Lonza Recent Development Table 80. Yidie Company Information Table 81. Yidie Business Overview Table 82. Yidie EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Yidie EPA and DHA Product Portfolio Table 84. Yidie Recent Development Table 85. Stepan Company Information Table 86. Stepan Business Overview Table 87. Stepan EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Stepan EPA and DHA Product Portfolio Table 89. Stepan Recent Development Table 90. Runke Company Information Table 91. Runke Business Overview Table 92. Runke EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Runke EPA and DHA Product Portfolio Table 94. Runke Recent Development Table 95. Novotech Nutraceuticals Company Information Table 96. Novotech Nutraceuticals Business Overview Table 97. Novotech Nutraceuticals EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Novotech Nutraceuticals EPA and DHA Product Portfolio Table 99. Novotech Nutraceuticals Recent Development Table 100. Kingdomway Company Information Table 101. Kingdomway Business Overview Table 102. Kingdomway EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Kingdomway EPA and DHA Product Portfolio Table 104. Kingdomway Recent Development Table 105. Fuxing Company Information Table 106. Fuxing Business Overview Table 107. Fuxing EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Fuxing EPA and DHA Product Portfolio Table 109. Fuxing Recent Development Table 110. Cabio Company Information Table 111. Cabio Business Overview Table 112. Cabio EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Cabio EPA and DHA Product Portfolio Table 114. Cabio Recent Development Table 115. Arjuna Natural Company Information Table 116. Arjuna Natural Business Overview Table 117. Arjuna Natural EPA and DHA Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Arjuna Natural EPA and DHA Product Portfolio Table 119. Arjuna Natural Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. EPA and DHA Distributors List Table 123. EPA and DHA Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. EPA and DHA Product Image Figure 2. Global EPA and DHA Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EPA and DHA Sales Value (2021-2032) & (US$ Million) Figure 4. Global EPA and DHA Sales (2021-2032) & (K Tons) Figure 5. Global EPA and DHA Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global EPA and DHA Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. EPA Image Figure 10. DHA Image Figure 11. Global EPA and DHA Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global EPA and DHA Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global EPA and DHA Sales Volume Share by Type (2021-2032) Figure 14. Global EPA and DHA Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global EPA and DHA Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global EPA and DHA Sales Value Share by Type (2021-2032) Figure 17. Infant Formula Image Figure 18. Food and Beverage Image Figure 19. Dietary Supplements Image Figure 20. Others Image Figure 21. Global EPA and DHA Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 22. Global EPA and DHA Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global EPA and DHA Sales Volume Share by Application (2021-2032) Figure 24. Global EPA and DHA Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global EPA and DHA Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global EPA and DHA Sales Value Share by Application (2021-2032) Figure 27. Global EPA and DHA Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 28. Global EPA and DHA Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global EPA and DHA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global EPA and DHA Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America EPA and DHA Sales Value (2021-2032) & (US$ Million) Figure 32. North America EPA and DHA Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe EPA and DHA Sales Value (2021-2032) & (US$ Million) Figure 34. Europe EPA and DHA Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific EPA and DHA Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific EPA and DHA Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America EPA and DHA Sales Value (2021-2032) & (US$ Million) Figure 38. South America EPA and DHA Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa EPA and DHA Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa EPA and DHA Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt EPA and DHA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt EPA and DHA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt EPA and DHA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. EPA and DHA Value Chain Figure 126. Manufacturing Cost Structure Figure 127. EPA and DHA Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • EPA
  • DHA
Applications
  • Infant Formula
  • Food and Beverage
  • Dietary Supplements
  • Others
Companies covered
  • DSM
  • Tianhecheng
  • Lonza
  • Yidie
  • Stepan
  • Runke
  • Novotech Nutraceuticals
  • Kingdomway
  • Fuxing
  • Cabio
  • Arjuna Natural

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EPA and DHA Sales Value (2021-2032)
  4. 1.2.2 Global EPA and DHA Sales Volume (2021-2032)
  5. 1.2.3 Global EPA and DHA Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 EPA and DHA Market Dynamics
  1. 2.1 EPA and DHA Industry Trends
  2. 2.2 EPA and DHA Industry Drivers
  3. 2.3 EPA and DHA Industry Opportunities and Challenges
  4. 2.4 EPA and DHA Industry Restraints
3 EPA and DHA Market by Company
  1. 3.1 Global EPA and DHA Company Revenue Ranking in 2025
  2. 3.2 Global EPA and DHA Revenue by Company (2021-2026)
  3. 3.3 Global EPA and DHA Sales Volume by Company (2021-2026)
  4. 3.4 Global EPA and DHA Average Price by Company (2021-2026)
  5. 3.5 Global EPA and DHA Company Ranking (2024-2026)
  6. 3.6 Global EPA and DHA Company Manufacturing Base and Headquarters
  7. 3.7 Global EPA and DHA Company Product Type and Application
  8. 3.8 Global EPA and DHA Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global EPA and DHA Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 EPA and DHA Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 EPA and DHA Market by Type
  1. 4.1 EPA and DHA Type Introduction
  2. 4.1.1 EPA
  3. 4.1.2 DHA
  4. 4.2 Global EPA and DHA Sales Volume by Type
  5. 4.2.1 Global EPA and DHA Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global EPA and DHA Sales Volume by Type (2021-2032)
  7. 4.2.3 Global EPA and DHA Sales Volume Share by Type (2021-2032)
  8. 4.3 Global EPA and DHA Sales Value by Type
  9. 4.3.1 Global EPA and DHA Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global EPA and DHA Sales Value by Type (2021-2032)
  11. 4.3.3 Global EPA and DHA Sales Value Share by Type (2021-2032)
5 EPA and DHA Market by Application
  1. 5.1 EPA and DHA Application Introduction
  2. 5.1.1 Infant Formula
  3. 5.1.2 Food and Beverage
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Others
  6. 5.2 Global EPA and DHA Sales Volume by Application
  7. 5.2.1 Global EPA and DHA Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global EPA and DHA Sales Volume by Application (2021-2032)
  9. 5.2.3 Global EPA and DHA Sales Volume Share by Application (2021-2032)
  10. 5.3 Global EPA and DHA Sales Value by Application
  11. 5.3.1 Global EPA and DHA Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global EPA and DHA Sales Value by Application (2021-2032)
  13. 5.3.3 Global EPA and DHA Sales Value Share by Application (2021-2032)
6 EPA and DHA Regional Sales and Value Analysis
  1. 6.1 Global EPA and DHA Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EPA and DHA Sales by Region (2021-2032)
  3. 6.2.1 Global EPA and DHA Sales by Region: 2021-2026
  4. 6.2.2 Global EPA and DHA Sales by Region (2027-2032)
  5. 6.3 Global EPA and DHA Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global EPA and DHA Sales Value by Region (2021-2032)
  7. 6.4.1 Global EPA and DHA Sales Value by Region: 2021-2026
  8. 6.4.2 Global EPA and DHA Sales Value by Region (2027-2032)
  9. 6.5 Global EPA and DHA Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America EPA and DHA Sales Value (2021-2032)
  12. 6.6.2 North America EPA and DHA Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe EPA and DHA Sales Value (2021-2032)
  15. 6.7.2 Europe EPA and DHA Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific EPA and DHA Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific EPA and DHA Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America EPA and DHA Sales Value (2021-2032)
  21. 6.9.2 South America EPA and DHA Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa EPA and DHA Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa EPA and DHA Sales Value Share by Country, 2025 VS 2032
7 EPA and DHA Country-level Sales and Value Analysis
  1. 7.1 Global EPA and DHA Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EPA and DHA Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global EPA and DHA Sales by Country (2021-2032)
  4. 7.3.1 Global EPA and DHA Sales by Country (2021-2026)
  5. 7.3.2 Global EPA and DHA Sales by Country (2027-2032)
  6. 7.4 Global EPA and DHA Sales Value by Country (2021-2032)
  7. 7.4.1 Global EPA and DHA Sales Value by Country (2021-2026)
  8. 7.4.2 Global EPA and DHA Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA EPA and DHA Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA EPA and DHA Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA EPA and DHA Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada EPA and DHA Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada EPA and DHA Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada EPA and DHA Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico EPA and DHA Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico EPA and DHA Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico EPA and DHA Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany EPA and DHA Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany EPA and DHA Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany EPA and DHA Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France EPA and DHA Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France EPA and DHA Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France EPA and DHA Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. EPA and DHA Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. EPA and DHA Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. EPA and DHA Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy EPA and DHA Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy EPA and DHA Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy EPA and DHA Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain EPA and DHA Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain EPA and DHA Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain EPA and DHA Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia EPA and DHA Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia EPA and DHA Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia EPA and DHA Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands EPA and DHA Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands EPA and DHA Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands EPA and DHA Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries EPA and DHA Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries EPA and DHA Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries EPA and DHA Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China EPA and DHA Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China EPA and DHA Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China EPA and DHA Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan EPA and DHA Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan EPA and DHA Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan EPA and DHA Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea EPA and DHA Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea EPA and DHA Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea EPA and DHA Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India EPA and DHA Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India EPA and DHA Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India EPA and DHA Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia EPA and DHA Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia EPA and DHA Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia EPA and DHA Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia EPA and DHA Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia EPA and DHA Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia EPA and DHA Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil EPA and DHA Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil EPA and DHA Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil EPA and DHA Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina EPA and DHA Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina EPA and DHA Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina EPA and DHA Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile EPA and DHA Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile EPA and DHA Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile EPA and DHA Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia EPA and DHA Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia EPA and DHA Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia EPA and DHA Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru EPA and DHA Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru EPA and DHA Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru EPA and DHA Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia EPA and DHA Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia EPA and DHA Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia EPA and DHA Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel EPA and DHA Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel EPA and DHA Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel EPA and DHA Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE EPA and DHA Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE EPA and DHA Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE EPA and DHA Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey EPA and DHA Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey EPA and DHA Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey EPA and DHA Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran EPA and DHA Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran EPA and DHA Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran EPA and DHA Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt EPA and DHA Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt EPA and DHA Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt EPA and DHA Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DSM
  2. 8.1.1 DSM Company Information
  3. 8.1.2 DSM Business Overview
  4. 8.1.3 DSM EPA and DHA Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 DSM EPA and DHA Product Portfolio
  6. 8.1.5 DSM Recent Developments
  7. 8.2 Tianhecheng
  8. 8.2.1 Tianhecheng Company Information
  9. 8.2.2 Tianhecheng Business Overview
  10. 8.2.3 Tianhecheng EPA and DHA Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tianhecheng EPA and DHA Product Portfolio
  12. 8.2.5 Tianhecheng Recent Developments
  13. 8.3 Lonza
  14. 8.3.1 Lonza Company Information
  15. 8.3.2 Lonza Business Overview
  16. 8.3.3 Lonza EPA and DHA Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lonza EPA and DHA Product Portfolio
  18. 8.3.5 Lonza Recent Developments
  19. 8.4 Yidie
  20. 8.4.1 Yidie Company Information
  21. 8.4.2 Yidie Business Overview
  22. 8.4.3 Yidie EPA and DHA Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Yidie EPA and DHA Product Portfolio
  24. 8.4.5 Yidie Recent Developments
  25. 8.5 Stepan
  26. 8.5.1 Stepan Company Information
  27. 8.5.2 Stepan Business Overview
  28. 8.5.3 Stepan EPA and DHA Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Stepan EPA and DHA Product Portfolio
  30. 8.5.5 Stepan Recent Developments
  31. 8.6 Runke
  32. 8.6.1 Runke Company Information
  33. 8.6.2 Runke Business Overview
  34. 8.6.3 Runke EPA and DHA Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Runke EPA and DHA Product Portfolio
  36. 8.6.5 Runke Recent Developments
  37. 8.7 Novotech Nutraceuticals
  38. 8.7.1 Novotech Nutraceuticals Company Information
  39. 8.7.2 Novotech Nutraceuticals Business Overview
  40. 8.7.3 Novotech Nutraceuticals EPA and DHA Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novotech Nutraceuticals EPA and DHA Product Portfolio
  42. 8.7.5 Novotech Nutraceuticals Recent Developments
  43. 8.8 Kingdomway
  44. 8.8.1 Kingdomway Company Information
  45. 8.8.2 Kingdomway Business Overview
  46. 8.8.3 Kingdomway EPA and DHA Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kingdomway EPA and DHA Product Portfolio
  48. 8.8.5 Kingdomway Recent Developments
  49. 8.9 Fuxing
  50. 8.9.1 Fuxing Company Information
  51. 8.9.2 Fuxing Business Overview
  52. 8.9.3 Fuxing EPA and DHA Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Fuxing EPA and DHA Product Portfolio
  54. 8.9.5 Fuxing Recent Developments
  55. 8.10 Cabio
  56. 8.10.1 Cabio Company Information
  57. 8.10.2 Cabio Business Overview
  58. 8.10.3 Cabio EPA and DHA Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cabio EPA and DHA Product Portfolio
  60. 8.10.5 Cabio Recent Developments
  61. 8.11 Arjuna Natural
  62. 8.11.1 Arjuna Natural Company Information
  63. 8.11.2 Arjuna Natural Business Overview
  64. 8.11.3 Arjuna Natural EPA and DHA Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Arjuna Natural EPA and DHA Product Portfolio
  66. 8.11.5 Arjuna Natural Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EPA and DHA Value Chain Analysis
  2. 9.1.1 EPA and DHA Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EPA and DHA Sales Mode & Process
  6. 9.2 EPA and DHA Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EPA and DHA Distributors
  9. 9.2.3 EPA and DHA Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst